Further delineation of the SATB2 phenotype

[1]  Disorders with similar clinical phenotypes reveal underlying genetic interaction: SATB2 acts as an activator of the UPF3B gene , 2013, Human Genetics.

[2]  J. Hornick,et al.  SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours , 2013, Histopathology.

[3]  Wei Wu,et al.  From neural development to cognition: unexpected roles for chromatin , 2013, Nature Reviews Genetics.

[4]  M. Dixon,et al.  Bmp and Shh Signaling Mediate the Expression of satb2 in the Pharyngeal Arches , 2013, PloS one.

[5]  Huifang Zhou,et al.  Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. , 2013, Stem cells and development.

[6]  Yu-Qiang Ding,et al.  Expression of Transcription Factor Satb2 in Adult Mouse Brain , 2013, Anatomical record.

[7]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[8]  S. Mcconnell,et al.  A network of genetic repression and derepression specifies projection fates in the developing neocortex , 2012, Proceedings of the National Academy of Sciences.

[9]  M. Zeng,et al.  Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma Patients , 2012, PloS one.

[10]  M. Venâncio,et al.  Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region , 2012, Molecular Cytogenetics.

[11]  Toshiro K. Ohsumi,et al.  Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries , 2012, Cell.

[12]  O. Britanova,et al.  Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2 in specifying callosal neurons , 2012, Proceedings of the National Academy of Sciences.

[13]  M. Uhlén,et al.  A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer , 2012, British Journal of Cancer.

[14]  Gautier Koscielny,et al.  Ensembl 2012 , 2011, Nucleic Acids Res..

[15]  J. Fish,et al.  Satb2, modularity, and the evolvability of the vertebrate jaw , 2011, Evolution & development.

[16]  Paul Stothard,et al.  In-depth annotation of SNPs arising from resequencing projects using NGS-SNP , 2011, Bioinform..

[17]  Yusuke Nakamura,et al.  Common Variants in a Novel Gene, FONG on Chromosome 2q33.1 Confer Risk of Osteoporosis in Japanese , 2011, PloS one.

[18]  J. Rosenfeld,et al.  Case series: 2q33.1 microdeletion syndrome—further delineation of the phenotype , 2011, Journal of Medical Genetics.

[19]  M. Dixon,et al.  A cross‐species analysis of Satb2 expression suggests deep conservation across vertebrate lineages , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  Andre J. van Wijnen,et al.  A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program , 2010, Proceedings of the National Academy of Sciences.

[21]  F. Faravelli,et al.  The refinement of the critical region for the 2q31.2q32.3 deletion syndrome indicates candidate genes for mental retardation and speech impairment , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[22]  J. Clayton-Smith,et al.  4.5 Mb microdeletion in chromosome band 2q33.1 associated with learning disability and cleft palate. , 2009, European journal of medical genetics.

[23]  Jian-ming Li,et al.  Down‐regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer , 2009, The Journal of pathology.

[24]  J. Rosenfeld,et al.  Small Deletions of SATB2 Cause Some of the Clinical Features of the 2q33.1 Microdeletion Syndrome , 2009, PloS one.

[25]  R. Mansel,et al.  The mRNA expression of SATB1 and SATB2 in human breast cancer , 2009, Cancer Cell International.

[26]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[27]  E. Hatchwell,et al.  Toriello–Carey syndrome in a patient with a de novo balanced translocation [46,XY,t(2;14)(q33;q22)] interrupting SATB2 , 2009, Clinical genetics.

[28]  T. de Ravel,et al.  Another patient with a de novo deletion further delineates the 2q33.1 microdeletion syndrome. , 2009, European journal of medical genetics.

[29]  O. Britanova,et al.  Satb2 Is a Postmitotic Determinant for Upper-Layer Neuron Specification in the Neocortex , 2008, Neuron.

[30]  S. Mcconnell,et al.  Satb2 Regulates Callosal Projection Neuron Identity in the Developing Cerebral Cortex , 2008, Neuron.

[31]  V. Tarabykin,et al.  SATB2 interacts with chromatin‐remodeling molecules in differentiating cortical neurons , 2008, The European journal of neuroscience.

[32]  Tayard Desudchit,et al.  Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects , 2007, Human mutation.

[33]  A. Renieri,et al.  Clinical and molecular characterization of a patient with a 2q31.2‐32.3 deletion identified by array‐CGH , 2007, American journal of medical genetics. Part A.

[34]  I. Fariñas,et al.  SATB2 Is a Multifunctional Determinant of Craniofacial Patterning and Osteoblast Differentiation , 2006, Cell.

[35]  C. Paweletz,et al.  Isolation and Characterization of SATB2, a Novel AT-rich DNA Binding Protein Expressed in Development- and Cell-Specific Manner in the Rat Brain , 2006, Neurochemical Research.

[36]  M. Marazita,et al.  Medical Sequencing of Candidate Genes for Nonsyndromic Cleft Lip and Palate , 2005, PLoS genetics.

[37]  J. Vermeesch,et al.  The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients. , 2005, European journal of medical genetics.

[38]  O. Britanova,et al.  Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue‐specific manner and demonstrates cell‐type‐dependent expression in the developing mouse CNS , 2005, The European journal of neuroscience.

[39]  D. Bonthron,et al.  Identification of SATB2 as the cleft palate gene on 2q32-q33. , 2003, Human molecular genetics.

[40]  A. Green,et al.  A locus for isolated cleft palate, located on human chromosome 2q32. , 1999, American journal of human genetics.

[41]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1999, DNA research : an international journal for rapid publication of reports on genes and genomes.

[42]  M. Suyama,et al.  Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1998, DNA research : an international journal for rapid publication of reports on genes and genomes.